FIELD: medicine, neurology. SUBSTANCE: method involves administration of insulin-like growth factor-1 to patients with neuropathy caused by not abnormal insulin level at dose that decreases neuropathy symptoms. Composition for decrease of peripheral neuropathy caused by neurotoxic agent has practically pure insulin-like growth factor-1 and neurotoxic chemotherapeutic agent at mass ratio from 1:400 to 75:1. EFFECT: enhanced effectiveness of treatment. 20 cl, 6 tbl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF K-252A DERIVATIVES TO TREAT DISORDERS OF PERIPHERAL OR CENTRAL NERVOUS SYSTEMS AND EXCESSIVE CYTOKINE OUTPUT | 1997 |
|
RU2183959C2 |
| METHOD FOR TREATING NEURODEGENERATIVE DISORDER OR MYELINOGENESIS DISORDER | 1997 |
|
RU2266129C2 |
| PDGFRα ANTIBODIES FOR TREATING SECONDARY BONE TUMOUR | 2006 |
|
RU2502523C2 |
| METHOD FOR REDUCING NEUROTOXICITY CAUSED BY A COMPLEX OF ANTI-TUBERCULOSIS DRUGS IN EXPERIMENT | 2023 |
|
RU2820957C1 |
| USING COMPOUNDS BINDING TO SIGMA RECEPTOR LIGANDS FOR TREATING NEUROPATHIC PAIN PROGRESSION CAUSED BY CHEMOTHERAPY | 2009 |
|
RU2537226C2 |
| SIGMA-RECEPTOR LIGANDS FOR PREVENTING OR TREATING PAIN CAUSED BY CHEMOTHERAPY | 2010 |
|
RU2543382C2 |
| METHOD FOR MODELING DRUG NEUROTOXICITY USING COMPLEX OF ANTI-TUBERCULOSIS AND ANTIMICROBIAL DRUGS | 2022 |
|
RU2795524C1 |
| METHODS, COMPOSITIONS AND PRODUCTS FOR CANCER TREATMENT | 2007 |
|
RU2407527C2 |
| CONDENSED PYRROLO[2,3-C]CARBAZOL-6-ONES THAT ENHANCE ACTIVITY OF GAMMA-INTERFERON | 1997 |
|
RU2193037C2 |
| METHOD OF PRODUCTION OF NUCLEOSIDE PHOSPHORYLASE AND NUCLEOSIDASE INHIBITORS | 2004 |
|
RU2334757C2 |
